CN115501126A - 一种美白抗皱组合物、日化品 - Google Patents
一种美白抗皱组合物、日化品 Download PDFInfo
- Publication number
- CN115501126A CN115501126A CN202211358925.4A CN202211358925A CN115501126A CN 115501126 A CN115501126 A CN 115501126A CN 202211358925 A CN202211358925 A CN 202211358925A CN 115501126 A CN115501126 A CN 115501126A
- Authority
- CN
- China
- Prior art keywords
- weight
- whitening
- parts
- wrinkle
- percent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 93
- 230000001153 anti-wrinkle effect Effects 0.000 title claims abstract description 53
- 239000000203 mixture Substances 0.000 title claims abstract description 53
- 239000000126 substance Substances 0.000 title claims abstract description 28
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 42
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 34
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 34
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000004475 Arginine Substances 0.000 claims abstract description 25
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000008367 deionised water Substances 0.000 claims abstract description 18
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 18
- 239000006071 cream Substances 0.000 claims abstract description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 19
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 10
- -1 octyl glycol Chemical compound 0.000 claims description 10
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 8
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 229960005323 phenoxyethanol Drugs 0.000 claims description 5
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 4
- 229960000458 allantoin Drugs 0.000 claims description 4
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 4
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 3
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001340 alkali metals Chemical group 0.000 claims description 2
- 229960003237 betaine Drugs 0.000 claims description 2
- 229940094978 bis-peg-18 methyl ether dimethyl silane Drugs 0.000 claims description 2
- 229960001631 carbomer Drugs 0.000 claims description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 2
- 230000001815 facial effect Effects 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 229940078498 peg-5 glyceryl stearate Drugs 0.000 claims description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 17
- 230000003020 moisturizing effect Effects 0.000 abstract description 11
- 230000008021 deposition Effects 0.000 abstract description 8
- 230000007246 mechanism Effects 0.000 abstract description 5
- 238000013329 compounding Methods 0.000 abstract description 4
- 150000004676 glycans Chemical class 0.000 abstract description 3
- 229920001282 polysaccharide Polymers 0.000 abstract description 3
- 239000005017 polysaccharide Substances 0.000 abstract description 3
- 229920000832 Cutin Polymers 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 230000003647 oxidation Effects 0.000 abstract description 2
- 238000007254 oxidation reaction Methods 0.000 abstract description 2
- 239000011148 porous material Substances 0.000 abstract description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 35
- 210000003491 skin Anatomy 0.000 description 25
- 230000002354 daily effect Effects 0.000 description 22
- 239000002994 raw material Substances 0.000 description 17
- 230000000052 comparative effect Effects 0.000 description 16
- 239000000047 product Substances 0.000 description 15
- 239000002537 cosmetic Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- 229920002385 Sodium hyaluronate Polymers 0.000 description 9
- 229940010747 sodium hyaluronate Drugs 0.000 description 9
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000037394 skin elasticity Effects 0.000 description 6
- 230000037303 wrinkles Effects 0.000 description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- 108010020346 Polyglutamic Acid Proteins 0.000 description 5
- 239000012496 blank sample Substances 0.000 description 5
- 229920002674 hyaluronan Polymers 0.000 description 5
- 229960003160 hyaluronic acid Drugs 0.000 description 5
- 229920002643 polyglutamic acid Polymers 0.000 description 5
- 208000003351 Melanosis Diseases 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 206010040844 Skin exfoliation Diseases 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000036074 healthy skin Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 229960003966 nicotinamide Drugs 0.000 description 3
- 235000005152 nicotinamide Nutrition 0.000 description 3
- 239000011570 nicotinamide Substances 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- RJZNPROJTJSYLC-LLINQDLYSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O RJZNPROJTJSYLC-LLINQDLYSA-N 0.000 description 2
- 241000208681 Hamamelis virginiana Species 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- 241000208467 Macadamia Species 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- WSGCRSMLXFHGRM-DEVHWETNSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O WSGCRSMLXFHGRM-DEVHWETNSA-N 0.000 description 1
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241001076416 Dendrobium tosaense Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 108010058643 Fungal Proteins Proteins 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- BNMGUJRJUUDLHW-HCZMHFOYSA-N Madecassoside Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(C[C@@H](O)[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O BNMGUJRJUUDLHW-HCZMHFOYSA-N 0.000 description 1
- BNMGUJRJUUDLHW-HLUHVYOBSA-N Madecassoside Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5[C@H](O)C[C@@]34C)[C@@H]2[C@H]1C)C(=O)O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O BNMGUJRJUUDLHW-HLUHVYOBSA-N 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 241001506047 Tremella Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229940095094 acetyl hexapeptide-8 Drugs 0.000 description 1
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-N hydroperoxyl Chemical compound O[O] OUUQCZGPVNCOIJ-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 229940090813 madecassoside Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000008132 rose water Substances 0.000 description 1
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical group OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Cosmetics (AREA)
Abstract
Description
技术领域
本发明涉及日化新材料领域,具体为一种美白抗皱组合物、日化品。
背景技术
CN112641669A公开了一种含有透明质酸的组合物,包含以下有效成分:交联透明质酸或其盐、非交联透明质酸或其盐、甘油葡糖苷以及羟基积雪草苷。
CN114569490A公开一种具有保湿和修复皮肤屏障以及抗皱紧致功效的组合物及其制备方法和用途。本发明组合物包含木糖醇及其衍生物保湿因子组合物和低分子量透明质酸硅烷醇组合物。
CN113101237A公开一种具有抗皱功效的聚谷氨酸及在化妆品中的应用,针对现有的聚谷氨酸不具备抗皱功效,不能满足人们的使用需求问题,现提出如下方案,其聚谷氨酸包括以下重量份的原料:聚谷氨酸20-30份、维生素E1-5份、海藻糖0.5-3份、乙酰基六肽0.5-3份、胶原蛋白1-5份、北美金缕梅提取物2-6份,其制备方法包括以下步骤:S1、将聚谷氨酸、维生素E、海藻糖、乙酰基六肽、胶原蛋白、北美金缕梅提取物混合均匀,制得混合物A;S2、将混合物A与维生素A、硫辛酸、虾青素、葡萄籽提取物、茶叶提取物、茄红素,混合均匀。
CN111214417A公开了一种具有紧致抗皱功效的酵母精华液及其在化妆品中的应用。所述精华液,有以下原料制备而成:二裂酵母发酵产物溶胞物,玫瑰花水,甘油,海藻糖,羧甲基脱乙酰壳多糖,透明质酸钠,水解胶原,水解燕麦蛋白,水解酵母蛋白,甘油硬脂酸酯,乙酰基六肽-8,棕榈酰五肽-4,类蛇毒三肽,铁皮石斛提取物,银耳提取物,猴面包树籽提取物,山茶籽油,生育酚,猴面包树籽油,辛甘醇,苯氧乙醇,羟苯甲酯,丙烯酸羟乙酯/丙烯酰二甲基牛磺酸钠共聚物,余量水。
CN202110275920.4公开了一种多羟丙基精氨酸及其衍生物-多羟基糖复合物及其制备方法和应用,多羟丙基精氨酸及其衍生物和多羟基糖通过氢键缔合形成复合结构。多羟丙基精氨酸及衍生物分子是将甘油和精氨酸及其衍生物融合形成的活性成分;甘油为高效保湿成分;精氨酸及衍生物是天然保湿因子成分,其携带的正电荷与皮肤或受损毛发产生强静电吸附力,结合甘油部分的羟基氧及精氨酸及衍生物的氮基团,容易与皮肤/受损毛发等其他氢键供体形成氢键,带来长效持久保湿效果。
其在说明书的90段记载:0.3%多羟丙基精氨酸和0.3%~2%的其他类型的生物活性糖的复配协同沉积机制。通过复配机制,果酸去角质沐浴乳提升了洗后界面沉积物的均匀程度,形成一层致密的沉积膜状结构,从而达到有效的保湿网络结构。
在上述对比文件中公开了多羟丙基精氨酸及其衍生物-多羟基糖复合物具有形成致密沉积膜的作用,其能够起到保湿的效果,特别对于洗脱型产品来说,其洗脱后存在致密沉积膜。
所以,本案解决的技术问题是:如何在其成膜机理上进一步开发,得到美白抗皱的日化品。
发明内容
本发明的目的在于提供一种美白抗皱组合物,该组合物利用多羟丙基精氨酸和多糖复配成膜的机理,结合60本身所具有的紧致作用,能够让使用者的肌肤表面形成紧致的沉积膜,同时,采用SRC和酵母亮白精华协同作用,可达到保湿、美白、抗皱的效果,SRC和酵母亮白精华在沉积膜的作用下,会更容易进入毛孔之中,促进角质剥脱来抗氧化,促进酵母亮白精华的美白功效。
同时,本发明还公开了一种日化品及其制备方法。
为实现上述目的,本发明提供如下技术方案:一种美白抗皱组合物,包括0.05~3重量份的60、1重量份的多羟丙基精氨酸及其衍生物、1~7重量份的海藻糖、2.5~25重量份的SRC、2.5~25重量份的酵母亮白精华、去离子水补至100重量份。
在上述的美白抗皱组合物中,所述多羟丙基精氨酸及其衍生物为的结构如式Ⅰ所示:
式Ⅰ中,X为氢原子或-CH2CH(OH)CH2(OH);Y为氢原子、碱金属、铵、有机铵或-CH2CH(OH)CH2(OH)。
同时,本发明还公开了一种美白抗皱护肤日化品,含有1-20wt%的如上任一所述的组合物。
优选地,一种美白抗皱护肤日化品,含有2-18wt%的如上任一所述的组合物。
优选地,一种美白抗皱护肤日化品,含有3-17wt%的如上任一所述的组合物。
优选地,一种美白抗皱护肤日化品,含有3-16wt%的如上任一所述的组合物。
优选地,一种美白抗皱护肤日化品,含有4-17wt%的如上任一所述的组合物。
优选地,一种美白抗皱护肤日化品,含有5-16wt%的如上任一所述的组合物。
优选地,一种美白抗皱护肤日化品,含有6-15wt%的如上任一所述的组合物。
优选地,一种美白抗皱护肤日化品,含有7-14wt%的如上任一所述的组合物。
优选地,一种美白抗皱护肤日化品,含有8-13wt%的如上任一所述的组合物。
优选地,一种美白抗皱护肤日化品,含有9-12wt%的如上任一所述的组合物。
优选地,一种美白抗皱护肤日化品,含有10-11wt%的如上任一所述的组合物。
在上述的美白抗皱护肤日化品中,所述日化品为洁面乳、面膜、化妆水、精华液、乳液、膏霜之一。
在上述的美白抗皱护肤日化品中,所述日化品为精华,包括如下配方:
聚乙二醇-75 5%;
甜菜碱1%;
甘草酸二钾0.05%;
尿囊素0.1%;
EDTA二钠0.05%;
丁二醇5%;
甘油3%;
黄原胶0.3%;
美白抗皱组合物1~20%;
苯氧乙醇0.5%;
对羟基苯乙酮0.5%;
辛甘醇0.05%;
Tween-20 0.2%;
水to 100%。
在上述的美白抗皱护肤日化品中,所述日化品为乳液,包括如下配方:
卡波姆0.2%;
尿囊素0.2%;
聚乙二醇-8 2%;
1,3-丙二醇3%;
双-PEG-18甲基醚二甲基硅烷1%;
聚二甲基硅氧烷2%;
季戊四醇四(乙基己酸)酯3%;
甘油硬脂酸酯1%;
PEG-5甘油硬脂酸酯1%;
精氨酸0.24%;
丁二醇3%;
美白抗皱组合物1~20%;
辛甘醇0.03%;
对羟基苯乙酮0.5%;
苯氧乙醇0.5%;
水to 100%。。
在本发明中,美白抗皱精华的制备工艺为:
步骤1:清洁并消毒所需设备,准确称量配方中各组分原料,用干净消毒好的器皿盛放备用。
步骤2:将原料1~9(参考下文表1)加入水锅中,搅拌升温至80-85℃,搅拌至全部溶解。
步骤3:将水锅料体抽入主锅,开启降温。
步骤4:降温至45℃,加入原料10~14(参考下文表1),搅拌均匀。
步骤5:取样检测各项理化指标,合格后过滤出料。
在本发明中,美白抗皱乳液的制备工艺为:
步骤1:清洁并消毒所需设备,准确称量配方中各组分原料,用干净消毒好的器皿盛放备用。
步骤2:将原料1~6(参考下文表2)加入水锅中,搅拌升温至80-85℃,搅拌至全部溶解。
步骤3:将原料7~10(参考下文表2)加入油锅中,搅拌升温至80-85℃,搅拌至全部溶解。
步骤4:将水锅,油锅原料抽入主锅,均质搅拌均匀后,加入预先溶解好的原料11~12(参考下文表2),开启降温。
步骤5:降温至45℃,加入原料13~17(参考下文表2),搅拌均匀。
步骤6:取样检测各项理化指标,合格后过滤出料。
与现有技术相比,本发明的有益效果是:
其中,60具有紧致弹性的作用,其主要成分为60%透明质酸钠、40%水解透明质酸钠;HA60为一种全分子量的透明质酸;可见CN113512134A,其重均分子量范围为0.2万~150万,分子量分散系数Mw/Mn在5以上;HA60由山东贯天下生物科技有限公司提供。
SRC为生物发酵衍生而来的肌肤重修寡肽,皮肤的更新(去角质)通过断开老化角质细胞间的附着物完成,老化的皮肤往往容易遭受到严重的干燥、粗糙和脱屑的现象,而且容易出现冬季性湿疹,水和pH值对皮肤自然脱落酶的活性起到重要的作用,DelmalRx SRC-r是通过使用专有的酵母菌株,生物发酵而来的,其主要成分是水,酵母菌发酵产物滤液,1,2-己二醇,对羟基苯乙酮;
SRC在本配方中和60、多羟丙基精氨酸及其衍生物、海藻糖、酵母亮白精华密切配合,多羟丙基精氨酸及其衍生物、海藻糖能够形成沉积膜,提供给SRC良好的修复所需水分和稳定的膜环境;酵母亮白精华在SRC作用下,能够作用于更新的肌肤提高美白效果;60不仅能够和多羟丙基精氨酸及其衍生物、海藻糖协同形成更为紧致的沉积膜,其还能够促进新生几乎保持弹性,起到更加的除皱效果。
具体实施方式
基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
在进行阐述本发明的方案之前,先阐述各原料的来源:
多羟丙基精氨酸及其衍生物(商品名:Amitose R-PD):SEIWA KASEI CO.,LTD.
海藻糖(商品名:TREHALOSE 100):林原株式会社
SRC(商品名:DermalRx SRC-R):Biocogent,LLC.
酵母亮白精华(商品名:NATRIANCE BRIGHTENER):Ashland(China)Holdings Co.,Ltd。
实施例1
多羟丙基精氨酸和海藻糖通过氢键缔合形成的复配物如式Ⅲ所示:
式Ⅲ中,X为-CH2CH(OH)CH2(OH);Y为氢原子;R-OH为海藻糖。
实施例2
实施例3
实施例4
实施例5
对比例1
大体同实施例1,不同的地方在于:将SRC用酵母-β-葡聚糖替代。
对比例2
大体同实施例1,不同的地方在于:将酵母亮白精华采用同等重量的烟酰胺替代。
烟酰胺:荷兰帝斯曼DSM。
对比例3
对比例4
大体同实施例1,不同的地方在于,60用等量的分子量8000-20,000的透明质酸钠和分子量20,000-200,000的透明质酸钠替代,分子量8000-20,000的透明质酸钠和分子量20,000-200,000的透明质酸钠的重量比例为1:1。
实施例6
一种美白抗皱精华,包括如下配方,参考表1;
表1配方表
此外还按照上述实施例6,去除美白抗皱组合物,得到空白样。
实施例7
一种美白抗皱乳液,包括如下配方,参考表2;
表2配方表
性能测试
测试项目1:皮肤含水量
选择健康肌肤正常、无化妆品过敏史受试人群,年龄25-40岁,共50人,按照实施例1-5及对比例1-4及空白样分为10组,每组5人,涂抹前将面部清洁干净,待皮肤晾干后涂抹对应产品,使用量为2mg/cm2,涂抹至样品吸收,涂抹产品0h、1h、2h、4h、6h后,选用德国CK公司皮肤水分测试探头CM825,在20℃和50%相对湿度环境下测试面颊部皮肤含水量,取各组平均值,结果见表3。
表3皮肤含水量的变化
由此可知,本发明提供的组合物具有较好的保湿功效。
测试项目2:皮肤弹性测量
选择健康肌肤正常、无化妆品过敏史受试人群,年龄25-40岁,共50人,按照实施例1-5及对比例1-4及空白样分为10组,每组5人,涂抹前将面部清洁干净,待皮肤晾干后涂抹对应产品,各组每天涂抹对应产品2次,连续4周,选用德国CK公司生产的PVM600型号的皮肤弹性探头测量使用产品后0、1、2、4周的皮肤弹性性能变化,测量结果用一个指数来表示,单位为1,数值越大,说明皮肤弹性越强,取各组的平均值,结果见表4。
表4皮肤弹性的变化
由此可知,本发明提供的组合物能够很好地促进皮肤的弹性,从而起到抗皱、紧致的功效。
测试项目3:皮肤黑色素值,斑点数量的变化
选择健康肌肤正常、无化妆品过敏史受试人群,年龄25-40岁,共50人,按照实施例1-5及对比例1-4及空白样分为10组,每组5人,涂抹前将面部清洁干净,待皮肤晾干后涂抹对应产品,各组每天涂抹对应产品2次,连续4周,选用Mexameter MX18、VISIA仪器,测量使用产品后0、2、4周的皮肤黑色素值(左右脸颊),斑点数量(全脸)的变化,结果见表5,表6。
表5皮肤黑色素值的变化
试验组 | 0周 | 2周 | 4周 |
实施例1 | 194.54±43.88 | 184.12±44.83 | 168.64±45.10 |
实施例2 | 192.31±44.12 | 185.43±43.80 | 174.49±43.39 |
实施例3 | 196.38±44.84 | 188.83±45.11 | 178.58±43.64 |
实施例4 | 195.32±45.60 | 189.92±44.67 | 181.42±44.82 |
实施例5 | 194.10±43.96 | 190.09±45.13 | 183.92±45.40 |
对比例1 | 195.89±44.19 | 189.35±43.98 | 180.11±44.30 |
对比例2 | 193.74±43.99 | 187.01±44.14 | 181.61±45.84 |
对比例3 | 195.14±44.85 | 187.84±44.82 | 173.42±44.18 |
对比例4 | 193.99±43.87 | 186.65±44.18 | 177.36±44.41 |
空白样 | 194.30±45.28 | 187.82±43.79 | 177.59±44.63 |
表6皮肤斑点数量的变化
由此可知,本发明提供的组合物能够很好地降低皮肤的黑色素值,减少皮肤斑点数量,从而起到美白的功效。
结果分析:
1.通过实施例1、空白样、对比例1-3可以发现:60、多羟丙基精氨酸及其衍生物、海藻糖、SRC、酵母亮白精华的配合是最优的,在缺失60、SRC、酵母亮白精华的情况下,其皮肤水分、斑点、弹性均变差;同时对比例1-3和空白样可以发现,60、多羟丙基精氨酸及其衍生物、海藻糖、SRC、酵母亮白精华中任一四者的配合均可以起到一定的效果;同时对比例2和实施例1的对比可以发现,作为功能相似的酵母亮白精华、烟酰胺,酵母亮白精华在本发明的配方中更有效;
2.通过实施例2-5以及对比例1-3的对比可以发现,在某些成分缺失的情况下,其效果会优于其他复配的情况,比如在不含SRC的情况,其祛斑效果会优于实施例5,这也说明在祛斑方面,SRC并非扮演非常重要的角色,但是根据实施例1和对比例1的对比可以发现,其是一个能够显著增效的角色。究其原因来说,SRC在本配方中和60、多羟丙基精氨酸及其衍生物、海藻糖、酵母亮白精华密切配合,多羟丙基精氨酸及其衍生物、海藻糖能够形成沉积膜,提供给SRC良好的修复所需水分和稳定的膜环境;所以,SRC在祛斑方面起着促进的作用。
通过含水率、皮肤弹性和祛斑效果的测试的结果可见,本发明的美白抗皱组合物可起到保湿、美白、抗皱的效果,SRC和酵母亮白精华在沉积膜的作用下,会更容易进入毛孔之中,促进角质剥脱来抗氧化,促进酵母亮白精华的美白功效。
Claims (8)
5.一种美白抗皱护肤日化品,其特征在于,含有1-20wt%的如权利要求1-4任一所述的组合物。
6.根据权利要求5所述的美白抗皱护肤日化品,其特征在于,所述日化品为洁面乳、面膜、化妆水、精华液、乳液、膏霜之一。
7.根据权利要求5所述的美白抗皱护肤日化品,其特征在于,所述日化品为精华,包括如下配方:
聚乙二醇-75 5%;
甜菜碱1%;
甘草酸二钾0.05%;
尿囊素0.1%;
EDTA二钠0.05%;
丁二醇5%;
甘油3%;
黄原胶0.3%;
美白抗皱组合物1~20%;
苯氧乙醇0.5%;
对羟基苯乙酮0.5%;
辛甘醇0.05%;
Tween-20 0.2%;
水to 100%。
8.根据权利要求5所述的美白抗皱护肤日化品,其特征在于,所述日化品为乳液,包括如下配方:
卡波姆0.2%;
尿囊素0.2%;
聚乙二醇-8 2%;
1,3-丙二醇3%;
双-PEG-18甲基醚二甲基硅烷1%;
聚二甲基硅氧烷2%;
季戊四醇四(乙基己酸)酯3%;
甘油硬脂酸酯1%;
PEG-5甘油硬脂酸酯1%;
精氨酸0.24%;
丁二醇3%;
美白抗皱组合物1~20%;
辛甘醇0.03%;
对羟基苯乙酮0.5%;
苯氧乙醇0.5%;
水to 100%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211358925.4A CN115501126A (zh) | 2022-11-01 | 2022-11-01 | 一种美白抗皱组合物、日化品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211358925.4A CN115501126A (zh) | 2022-11-01 | 2022-11-01 | 一种美白抗皱组合物、日化品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115501126A true CN115501126A (zh) | 2022-12-23 |
Family
ID=84512784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211358925.4A Pending CN115501126A (zh) | 2022-11-01 | 2022-11-01 | 一种美白抗皱组合物、日化品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115501126A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107822946A (zh) * | 2017-10-10 | 2018-03-23 | 广州柏俐臣化妆品有限公司 | 一种涂抹式水光瓷肌精华液及其制备方法 |
CN110623882A (zh) * | 2019-10-21 | 2019-12-31 | 广州艾蓓生物科技有限公司 | 一种美白祛斑面膜及其制备方法 |
CN111214417A (zh) * | 2020-03-10 | 2020-06-02 | 广州澳特朗生物技术有限公司 | 一种具有紧致抗皱功效的酵母精华液及其制备方法与应用 |
CN112957270A (zh) * | 2021-03-15 | 2021-06-15 | 茵素科技(广州)有限公司 | 一种多羟丙基精氨酸及其衍生物-多羟基糖复合物及其制备方法和应用 |
CN113648275A (zh) * | 2021-09-09 | 2021-11-16 | 广东星芮生物科技有限公司 | 美白抗皱组合物及复合发酵美白抗皱精华液及其制备工艺 |
-
2022
- 2022-11-01 CN CN202211358925.4A patent/CN115501126A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107822946A (zh) * | 2017-10-10 | 2018-03-23 | 广州柏俐臣化妆品有限公司 | 一种涂抹式水光瓷肌精华液及其制备方法 |
CN110623882A (zh) * | 2019-10-21 | 2019-12-31 | 广州艾蓓生物科技有限公司 | 一种美白祛斑面膜及其制备方法 |
CN111214417A (zh) * | 2020-03-10 | 2020-06-02 | 广州澳特朗生物技术有限公司 | 一种具有紧致抗皱功效的酵母精华液及其制备方法与应用 |
CN112957270A (zh) * | 2021-03-15 | 2021-06-15 | 茵素科技(广州)有限公司 | 一种多羟丙基精氨酸及其衍生物-多羟基糖复合物及其制备方法和应用 |
CN113648275A (zh) * | 2021-09-09 | 2021-11-16 | 广东星芮生物科技有限公司 | 美白抗皱组合物及复合发酵美白抗皱精华液及其制备工艺 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6054858B2 (ja) | Has2−刺激性植物抽出物 | |
KR20150139298A (ko) | 홍국 추출물을 함유하는 보습용 피부 외용제 조성물 | |
CN110585048A (zh) | 一种具有抗糖化和抗氧化的组合物及其应用 | |
EP2612654B1 (en) | Cosmetic composition for improving skin elasticity | |
CN113648275A (zh) | 美白抗皱组合物及复合发酵美白抗皱精华液及其制备工艺 | |
CN115607499A (zh) | 一种用于抗皱紧致的人参灵芝多肽组合物及其应用 | |
CN114053191B (zh) | 一种抗衰老组合物及其制备方法与应用 | |
CN108175737A (zh) | 一种抗牙结石中药牙膏及其制备方法 | |
KR102291780B1 (ko) | 천연 유래 물질을 포함하는 피부 노화 예방 및 상처 치유용 기능성 화장료 조성물 및 이의 제조방법 | |
JP2001131049A (ja) | 皮膚外用剤 | |
CN114099393A (zh) | 一种具有紧致与抗衰功效的组合物及其制备方法和应用 | |
CN115501126A (zh) | 一种美白抗皱组合物、日化品 | |
KR101708459B1 (ko) | 다시마추출물, 미역추출물 및 차전자추출물을 함유하는 피부 보습 및 탄력용 화장료 조성물 | |
JP2010184916A (ja) | 育毛剤 | |
CN115400052A (zh) | 一种胭脂树红护肤沙霜及其制备方法 | |
KR20110097301A (ko) | 저분자 후코이단, 비타민나무 추출물 및 니아신아마이드가 함유된 피부 미백용 화장료 조성물 및 그 제조방법 | |
CN110974770A (zh) | 抗衰老组合物、制剂及制备方法 | |
KR20210093498A (ko) | 타나카추출물을 함유하는 화장료 조성물 | |
CN115869230B (zh) | 一种抗皱化妆品及其制备方法 | |
CN117919132B (zh) | 一种组合物、用途和精华液 | |
CN118304226B (zh) | 一种含有金花茶提取物的屏障修护组合物及其制备方法和应用 | |
KR102525091B1 (ko) | 천연 복합 추출물을 유효성분으로 포함하는 모공 수축용 화장료 조성물 | |
KR102428868B1 (ko) | 마이크로바이옴 병풀 발효물이 포함된 화장료 조성물 | |
CN115869230A (zh) | 一种抗皱化妆品及其制备方法 | |
CN116370361B (zh) | 一种抗衰组合物及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20221223 |